DHR 197.9 (-3.54%)
US2358511028Medical Diagnostics & ResearchDiagnostics & Research

Danaher (DHR) Competitor Comparison

We are evaluating the key criteria listed to compare Danaher (DHR) against its competitors in the Diagnostics & Research industry.

Linearity 10 years - DHR ranking 49 / 58

These are the competitors of Danaher in the industry Diagnostics & Research ranked by linearity 10 years
1. Inotiv NOTV
139.98
2. National Research NRC
51.04
3. Ortho Clinical Diagnostics Holdings OCDX
33.4
4. Guardant Health GH
8.32
5. Olink Holding OLK
8.11
6. Anixa Biosciences ANIX
7.89
7. Neogen NEOG
7.17
8. NeoGenomics NEO
6.54
9. Fulgent Genetics FLGT
6.43
10. Illumina ILMN
5.81
11. Global Cord Blood CO
5.67
12. DarioHealth DRIO
4.86
13. Pacific Biosciences of California PACB
4.75
14. Qiagen QGEN
4.73
15. Exact Sciences EXAS
4.65
16. Syneos Health SYNH
3.71
17. Sotera Health SHC
3.68
18. Charles River Laboratories CRL
3.49
19. Co-Diagnostics CODX
3.21
20. Bioventus BVS
3.1
21. Enzo Biochem ENZ
3.08
22. Myriad Genetics MYGN
2.99
23. Twist Bioscience TWST
2.88
24. CareDx CDNA
2.66
25. Psychemedics PMD
2.47
26. Sera Prognostics SERA
2.42
27. Aspira Womens Health AWH
2.28
28. Exagen XGN
2.27
29. Icon ICLR
2.13
30. Meridian Bioscience VIVO
2.1
31. MDxHealth MDXH
1.91
32. bioAffinity Technologies BIAF
1.9
33. Biodesix BDSX
1.87
34. IQVIA Holdings IQV
1.81
35. Personalis PSNL
1.8
36. MaxCyte MXCT
1.8
37. Laboratory Corp of America Holdings LH
1.75
38. Prenetics Global PRE
1.71
39. Organovo Holdings ONVO
1.66
40. Neuronetics STIM
1.62
41. Trinity Biotech TRIB
1.57
42. Agilent Technologies A
1.54
43. DexCom DXCM
1.53
44. Quest Diagnostics DGX
1.5
45. SeqLL SQL
1.42
46. Interpace Biosciences IDXG
1.33
47. PerkinElmer PKI
1.15
48. Mettler-Toledo MTD
1.11
49. Danaher DHR
1.11
50. Precipio PRPO
1.09
51. Waters WAT
1.03
52. Thermo Fisher Scientific TMO
0.98
53. IDEXX Laboratories IDXX
0.89
54. Heska HSKA
0.52
55. Natera NTRA
0.4
56. Lantheus Holdings LNTH
0.32
57. RadNet RDNT
0.29
58. Medpace Holdings MEDP
0.23

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.